Sector consensus Charles River Laboratories International, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:20:33 2024-09-18 pm EDT			5-day change	1st Jan Change
207.49 ^USD	+0.62%		+7.43%	-12.02%

Sep. 17	Charles River Laboratories, CEBINA Partner to Accelerate Neurodegenerative Drug Development	MT
Sep. 10	Transcript : Charles River Laboratories International, Inc. Presents at Baird's 2024 Global Healthcare Conference, Sep-10-2024 10:15 AM

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m Revision of opinion	Average Target P.	Ecart obj. / dr	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		224.07	+8.66%	17
LONZA GROUP AG		624.14	+15.71%	21
IQVIA HOLDINGS INC.		276.53	+15.23%	21
ALNYLAM PHARMACEUTICALS, INC.		283.17	+3.17%	27
CELLTRION, INC.		248,000.00	+27.05%	19
MODERNA, INC.		99.84	+38.69%	19
ICON PUBLIC LIMITED COMPANY		365.40	+24.91%	15
UNITED THERAPEUTICS CORPORATION		350.71	+1.65%	13
BIO-TECHNE CORPORATION		83.09	+10.38%	13
MEDPACE HOLDINGS, INC.		406.91	+14.74%	9
QIAGEN N.V.		50.97	+11.64%	17
TEMPUS AI, INC		46.00	-6.56%	8
REVOLUTION MEDICINES, INC.		59.21	+35.29%	14
BACHEM HOLDING AG		82.83	+10.22%	6
IONIS PHARMACEUTICALS, INC.		62.67	+50.98%	25
HANGZHOU TIGERMED CONSULTING CO., LTD		69.52	+41.91%	16
BLUEPRINT MEDICINES CORPORATION	-	127.35	+47.21%	17
PHARMARON BEIJING CO., LTD.		22.97	+10.50%	12
ALKERMES PLC		34.69	+25.06%	13
Average		13,224.74	+20.34%	16
Weighted average by Cap.		24,238.53	+18.37%	18